Clinical trials in Zadar – page 2

Innovative research focusing on psoriatic arthritis, systemic sclerosis, and systemic lupus erythematosus. Clinical trials are evaluating new therapeutic approaches including zasocitinib and efgartigimod for improving patient outcomes.

• Psoriatic Arthritis Treatment
• Systemic Sclerosis Management
• Lupus Therapy Development

Studies aim to address both skin manifestations and systemic symptoms of these conditions.

Groundbreaking research in multiple sclerosis treatment, testing new therapeutic agents like remibrutinib compared to established treatments. Focus on reducing relapse frequency and improving patient quality of life.

• MS Relapse Prevention
• Novel Treatment Comparisons
• Disease Progression Management

Emphasis on developing more effective treatment options with better tolerability profiles.

Comprehensive studies on Crohn's disease, ulcerative colitis, and celiac disease. Trials evaluating innovative treatments including MORF-057, rosnilimab, and ZED1227 for improving disease management.

• Inflammatory Bowel Disease Therapy
• Celiac Disease Management
• Endoscopic Response Assessment

Research focuses on both symptom control and mucosal healing.

Advanced research in severe eosinophilic asthma and COPD. Studies evaluating dexpramipexole and CHF6001 DPI as potential treatments for improving respiratory function and reducing exacerbations.

• Asthma Exacerbation Prevention
• COPD Management
• Triple Therapy Enhancement

Focus on developing targeted therapies for severe respiratory conditions.

Important studies in atrial fibrillation and hypertriglyceridemia. Clinical trials examining new anticoagulants like milvexian and treatments for metabolic disorders.

• Stroke Prevention
• Lipid Management
• Cardiovascular Risk Reduction

Research aims to improve cardiovascular outcomes and prevent complications.